All Eyes On Amjevita, Amgen’s Humira Biosimilar And Sole 2023 Product Launch

Dual Pricing Strategy Addresses Unique US Payer Priorities

 
• By Mandy Jackson
  
Close-up Of man using Binoculars
Many are watching the Amjevita launch to see what it portends for uptake of other Humira biosimilars • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip